FTH Faeth Therapeutics, Inc.: institutional ownership and insider trading
47 funds reported holding $334M of Faeth Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $190M, with 22 new positions and 7 funds selling out; over the last 12 months insiders bought $2.53M and sold $2.28M on the open market.
Famous investors holding FTH
- Renaissance Technologies (Renaissance Technologies): $510K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $307K, 0.0% of the portfolio
Largest institutional holders of FTH
- SUVRETTA CAPITAL MANAGEMENT, LLC — $50.5M
- Avoro Capital Advisors LLC — $36.1M
- BAKER BROS. ADVISORS LP — $32.2M
- BALYASNY ASSET MANAGEMENT L.P. — $26.1M
- RA CAPITAL MANAGEMENT, L.P. — $18.1M
- Vivo Capital, LLC — $18.1M
- Logos Global Management LP — $18.1M
- Fairmount Funds Management LLC — $18.1M
- Caligan Partners LP — $15.7M
- B Group, Inc. — $15.3M
Recent FTH insider trades
- Jul 1, 2026: Stephenson Brian C bought 13,634 shares ($326K)
- Jun 26, 2026: Stephenson Brian C bought 15,641 shares ($401K)
- Jun 23, 2026: Stephenson Brian C bought 17,413 shares ($406K)
- Jun 22, 2026: Parikh Anand Kiran bought 2,806 shares ($55.4K)
5%+ owners
- VK Services, LLC: 10.2% (Schedule 13G, filed Aug 14, 2026)
- S2G Investments, LLC: 10.0% (Schedule 13G, filed Jun 23, 2026)
- Millennium Management LLC: 9.6% (Schedule 13G, filed May 15, 2026)
- Suvretta Capital Management, LLC: 7.8% (Schedule 13G, filed Jun 23, 2026)